sb 216763 has been researched along with fulvestrant in 1 studies
| Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (fulvestrant) | Trials (fulvestrant) | Recent Studies (post-2010) (fulvestrant) |
|---|---|---|---|---|---|
| 342 | 0 | 225 | 2,712 | 207 | 1,196 |
| Protein | Taxonomy | sb 216763 (IC50) | fulvestrant (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0061 | |
| Estrogen receptor | Rattus norvegicus (Norway rat) | 0.0059 | |
| Progesterone receptor | Homo sapiens (human) | 0.0002 | |
| Steroid hormone receptor ERR1 | Homo sapiens (human) | 0.002 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.006 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0104 | |
| Bile acid receptor | Homo sapiens (human) | 0.79 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, G; Cao, L; Gao, H; Gui, S; Lu, R; Wang, F; Zhang, Y | 1 |
1 other study(ies) available for sb 216763 and fulvestrant
| Article | Year |
|---|---|
Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Topics: Animals; Cell Line, Transformed; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Indoles; Intercellular Signaling Peptides and Proteins; Maleimides; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344; Time Factors | 2014 |